Hsueh, W.-T.; Chen, S.-H.; Chien, C.-H.; Chou, S.-W.; Chi, P.-I.; Chu, J.-M.; Chang, K.-Y.
SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer. Int. J. Mol. Sci. 2021, 22, 11260.
https://doi.org/10.3390/ijms222011260
AMA Style
Hsueh W-T, Chen S-H, Chien C-H, Chou S-W, Chi P-I, Chu J-M, Chang K-Y.
SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer. International Journal of Molecular Sciences. 2021; 22(20):11260.
https://doi.org/10.3390/ijms222011260
Chicago/Turabian Style
Hsueh, Wei-Ting, Shang-Hung Chen, Chia-Hung Chien, Shao-Wen Chou, Pei-I Chi, Jui-Mei Chu, and Kwang-Yu Chang.
2021. "SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer" International Journal of Molecular Sciences 22, no. 20: 11260.
https://doi.org/10.3390/ijms222011260
APA Style
Hsueh, W.-T., Chen, S.-H., Chien, C.-H., Chou, S.-W., Chi, P.-I., Chu, J.-M., & Chang, K.-Y.
(2021). SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer. International Journal of Molecular Sciences, 22(20), 11260.
https://doi.org/10.3390/ijms222011260
